company background image
M

Med LifeBVB:M Stock Report

Market Cap

RON2.6b

7D

-0.5%

1Y

211.8%

Updated

16 Oct, 2021

Data

Company Financials +
M fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance5/6
Financial Health3/6
Dividends0/6

M Overview

Med Life S.A. operates as a private healthcare provider in Romania.

Med Life Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Med Life
Historical stock prices
Current Share PriceRON19.85
52 Week HighRON6.33
52 Week LowRON20.20
Beta0.84
1 Month Change16.08%
3 Month Change16.42%
1 Year Change211.78%
3 Year Change341.11%
5 Year Changen/a
Change since IPO358.08%

Recent News & Updates

Aug 31
Does Med Life (BVB:M) Have A Healthy Balance Sheet?

Does Med Life (BVB:M) Have A Healthy Balance Sheet?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Jun 10
Med Life's (BVB:M) Returns On Capital Are Heading Higher

Med Life's (BVB:M) Returns On Capital Are Heading Higher

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

May 26
Here's Why We Think Med Life (BVB:M) Is Well Worth Watching

Here's Why We Think Med Life (BVB:M) Is Well Worth Watching

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Shareholder Returns

MRO HealthcareRO Market
7D-0.5%0.9%-0.7%
1Y211.8%9.6%42.4%

Return vs Industry: M exceeded the RO Healthcare industry which returned 9.6% over the past year.

Return vs Market: M exceeded the RO Market which returned 42.4% over the past year.

Price Volatility

Is M's price volatile compared to industry and market?
M volatility
M Beta0.84
Industry Beta0.97
Market Beta1

Stable Share Price: M is not significantly more volatile than the rest of RO stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: M's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19964,658Mihail Marcuhttps://www.medlife.ro

Med Life S.A. operates as a private healthcare provider in Romania. It operates through six business lines: Corporate, Clinics, Laboratories, Hospitals, Pharmacies, and Stomatology. The Corporate business line offers health prevention packages to corporate clients, which cover regular check-ups and access to diagnostic services.

Med Life Fundamentals Summary

How do Med Life's earnings and revenue compare to its market cap?
M fundamental statistics
Market CapRON2.61b
Earnings (TTM)RON110.95m
Revenue (TTM)RON1.30b

23.5x

P/E Ratio

2.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
M income statement (TTM)
RevenueRON1.30b
Cost of RevenueRON539.32m
Gross ProfitRON755.68m
ExpensesRON644.73m
EarningsRON110.95m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.84
Gross Margin58.35%
Net Profit Margin8.57%
Debt/Equity Ratio149.6%

How did M perform over the long term?

See historical performance and comparison

Valuation

Is Med Life undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: M (RON19.85) is trading below our estimate of fair value (RON40.96)

Significantly Below Fair Value: M is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: M is poor value based on its PE Ratio (23.5x) compared to the European Healthcare industry average (23.2x).

PE vs Market: M is poor value based on its PE Ratio (23.5x) compared to the RO market (14.3x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate M's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: M is overvalued based on its PB Ratio (8.6x) compared to the XE Healthcare industry average (2.3x).


Future Growth

How is Med Life forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

8.1%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if M's forecast earnings growth is above the savings rate (1.2%).

Earnings vs Market: Insufficient data to determine if M's earnings are forecast to grow faster than the RO market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: M's revenue (8.1% per year) is forecast to grow faster than the RO market (5.4% per year).

High Growth Revenue: M's revenue (8.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: M's Return on Equity is forecast to be high in 3 years time (23%)


Past Performance

How has Med Life performed over the past 5 years?

76.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: M has high quality earnings.

Growing Profit Margin: M's current net profit margins (8.6%) are higher than last year (1.6%).


Past Earnings Growth Analysis

Earnings Trend: M's earnings have grown significantly by 76% per year over the past 5 years.

Accelerating Growth: M's earnings growth over the past year (607.3%) exceeds its 5-year average (76% per year).

Earnings vs Industry: M earnings growth over the past year (607.3%) exceeded the Healthcare industry 40.8%.


Return on Equity

High ROE: Whilst M's Return on Equity (36.41%) is high, this metric is skewed due to their high level of debt.


Financial Health

How is Med Life's financial position?


Financial Position Analysis

Short Term Liabilities: M's short term assets (RON347.8M) do not cover its short term liabilities (RON355.2M).

Long Term Liabilities: M's short term assets (RON347.8M) do not cover its long term liabilities (RON573.1M).


Debt to Equity History and Analysis

Debt Level: M's debt to equity ratio (149.6%) is considered high.

Reducing Debt: M's debt to equity ratio has reduced from 215.2% to 149.6% over the past 5 years.

Debt Coverage: M's debt is well covered by operating cash flow (33.4%).

Interest Coverage: M's interest payments on its debt are well covered by EBIT (7.6x coverage).


Balance Sheet


Dividend

What is Med Life current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate M's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate M's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if M's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if M's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of M's dividend in 3 years as they are not forecast to pay a notable one for the RO market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.8yrs

Average management tenure


CEO

Mihail Marcu (51 yo)

4.83yrs

Tenure

Mr. Mihail Marcu serves as Chief Executive Officer at S.C. Med Life S.A. since December 2016. Mr. Marcu served as the Chief Executive Officer of MedLife between January 2004 until August 2006 and vice pres...


Leadership Team

Experienced Management: M's management team is considered experienced (4.8 years average tenure).


Board Members

Experienced Board: M's board of directors are seasoned and experienced ( 13.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Med Life S.A.'s employee growth, exchange listings and data sources


Key Information

  • Name: Med Life S.A.
  • Ticker: M
  • Exchange: BVB
  • Founded: 1996
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: RON2.611b
  • Shares outstanding: 131.53m
  • Website: https://www.medlife.ro

Number of Employees


Location

  • Med Life S.A.
  • Calea Grivitei, No. 365
  • District 1
  • Bucharest
  • Romania

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/16 16:45
End of Day Share Price2021/10/15 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.